Shanghai OPM Biosciences (SH:688293) Xin Lang Cai Jing·2025-10-27 06:44Core Viewpoint - The first biomanufacturing industry fund in Shanghai has been officially established, aiming to integrate resources from enterprises, universities, and research institutions to promote key technological breakthroughs and corporate growth [1] Group 1: Fund Structure and Collaboration - The fund is empowered by the State Investment Company under Shanghai Guotou and co-initiated by Daotong Investment and Aopumai [1] - It adopts a "C (main industry chain enterprises) + VC (professional investment institutions)" dual-driven model [1] Group 2: Strategic Focus - Aopumai is positioned as a leading enterprise in cell culture media, leveraging its industry advantages [1] - Daotong brings expertise in early-stage medical and synthetic biology investments, enhancing the fund's strategic focus [1]